Challenges and opportunities for proton therapy during pregnancy
© 2023 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG)..
During pregnancy, the use of radiation therapy for cancer treatment is often considered impossible due to the assumed associated fetal risks. However, suboptimal treatment of pregnant cancer patients and unjustifiable delay in radiation therapy until after delivery can be harmful for both patient and child. In non-pregnant patients, proton-radiation therapy is increasingly administered because of its favorable dosimetric properties compared with photon-radiation therapy. Although data on the use of pencil beam scanning proton-radiation therapy during pregnancy are scarce, different case reports and dosimetric studies have indicated a more than 10-fold reduction in fetal radiation exposure compared with photon-radiation therapy. Nonetheless, the implementation of proton-radiation therapy during pregnancy requires complex fetal dosimetry for the neutron-dominated out-of-field radiation dose and faces a lack of clinical guidelines. Further exploration and standardization of proton-radiation therapy during pregnancy will be necessary to improve radiotherapeutic management of pregnant women with cancer and further reduce risks for their offspring.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:103 |
---|---|
Enthalten in: |
Acta obstetricia et gynecologica Scandinavica - 103(2024), 4 vom: 24. Apr., Seite 767-774 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Blommaert, Jeroen [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cancer |
---|
Anmerkungen: |
Date Completed 05.04.2024 Date Revised 17.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/aogs.14645 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM359919332 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM359919332 | ||
003 | DE-627 | ||
005 | 20240418232247.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/aogs.14645 |2 doi | |
028 | 5 | 2 | |a pubmed24n1379.xml |
035 | |a (DE-627)NLM359919332 | ||
035 | |a (NLM)37491770 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Blommaert, Jeroen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Challenges and opportunities for proton therapy during pregnancy |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.04.2024 | ||
500 | |a Date Revised 17.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG). | ||
520 | |a During pregnancy, the use of radiation therapy for cancer treatment is often considered impossible due to the assumed associated fetal risks. However, suboptimal treatment of pregnant cancer patients and unjustifiable delay in radiation therapy until after delivery can be harmful for both patient and child. In non-pregnant patients, proton-radiation therapy is increasingly administered because of its favorable dosimetric properties compared with photon-radiation therapy. Although data on the use of pencil beam scanning proton-radiation therapy during pregnancy are scarce, different case reports and dosimetric studies have indicated a more than 10-fold reduction in fetal radiation exposure compared with photon-radiation therapy. Nonetheless, the implementation of proton-radiation therapy during pregnancy requires complex fetal dosimetry for the neutron-dominated out-of-field radiation dose and faces a lack of clinical guidelines. Further exploration and standardization of proton-radiation therapy during pregnancy will be necessary to improve radiotherapeutic management of pregnant women with cancer and further reduce risks for their offspring | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a cancer | |
650 | 4 | |a fetal radiation | |
650 | 4 | |a pregnancy | |
650 | 4 | |a proton therapy | |
650 | 4 | |a radiation therapy | |
650 | 7 | |a Protons |2 NLM | |
700 | 1 | |a De Saint-Hubert, Marijke |e verfasserin |4 aut | |
700 | 1 | |a Depuydt, Tom |e verfasserin |4 aut | |
700 | 1 | |a Oldehinkel, Edwin |e verfasserin |4 aut | |
700 | 1 | |a Poortmans, Philip |e verfasserin |4 aut | |
700 | 1 | |a Amant, Frederic |e verfasserin |4 aut | |
700 | 1 | |a Lambrecht, Maarten |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Acta obstetricia et gynecologica Scandinavica |d 1947 |g 103(2024), 4 vom: 24. Apr., Seite 767-774 |w (DE-627)NLM000123765 |x 1600-0412 |7 nnns |
773 | 1 | 8 | |g volume:103 |g year:2024 |g number:4 |g day:24 |g month:04 |g pages:767-774 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/aogs.14645 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 103 |j 2024 |e 4 |b 24 |c 04 |h 767-774 |